DRKS00024916招募中不适用
Bridging therapy of acute lymphoblastic leukemia before treatment with chimeric antigen receptor (CAR) T cells - Retrospective analysis for a guidance - ALL-Bridge 2 CAR
Dr. von Haunersches Kinderspital Klinikum der Universität München0 个研究点目标入组 35 人开始时间: 2021年5月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 30 Years（—）
- 性别
- All
入选标准
- •Patients until age of 30 suffering from relapsed/refractory B-lineage ALL with the decision to initiate CAR T-cell therapy. This age was chosen based on the approved age limit of 25 for the current CAR T-cell products with market authorization. It was extended to 30 to also take into account individual cases of curative treatments.
排除标准
- •Patients treated with CAR T-cells within the scope of a clinical study have to be excluded in case of conflict of interest with the sponsor.
研究者
相似试验
已完成
不适用
Treatment of acute lymphoblastic leukemia (ALL) in adults age 40 - 70 years inclusive with chemotherapy including a pre-induction course for rapid tumor load reduction and prolonged maintenance chemotherapyAcute Lymphoblastic LeukemiaLymphoid leukaemiaCancerISRCTN00446029Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (Netherlands)55
招募中
3 期
Acute Lymphoblastic Leukemia treatment protocol for children and adolescentRBR-6pmfz8Sociedade Brasileira de Oncologia Pediátrica (SOBOPE)
已完成
不适用
Acute lymphoblastic leukaemia (ALL) trial XII (joint trial with Eastern Co-operative Oncology Group - E2993)eukaemiaCancerLeukaemiaISRCTN77346223Medical Research Council (MRC) (UK)550
招募中
不适用
BRALLA protocolAcute lymphoblastic leukemiaC04.557.337RBR-10jpb6v7Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
招募中
2 期
Treatment protocol for adult acute lymphoblastic leukemia (-ALL/MRD2023-)acute lymphoblastic leukemiaJPRN-jRCTs071220071Koichi Akashi210